To Evaluate the Efficacy of Three Times Weekly (TIW) Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
Public ClinicalTrials.gov record NCT06901505. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis
Study identification
- NCT ID
- NCT06901505
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Akebia Therapeutics
- Industry
- Enrollment
- 353 participants
Conditions and interventions
Conditions
Interventions
- Erythropoiesis-Stimulating Agent (ESA) Drug
- Vadadustat Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 23, 2025
- Primary completion
- Jul 31, 2026
- Completion
- Jul 31, 2026
- Last update posted
- Feb 22, 2026
2025 – 2026
United States locations
- U.S. sites
- 18
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DaVita Research Site | Montgomery | Alabama | 36117-7306 | — |
| DaVita Research Site | Hartford | Connecticut | 06112-1260 | — |
| DaVita Research Site | Middlebury | Connecticut | 06705-3893 | — |
| DaVita Research Site | Columbus | Georgia | 31904-3604 | — |
| DaVita Research Site #1 | Minneapolis | Minnesota | 55435-1807 | — |
| DaVita Research Site | Minneapolis | Minnesota | 55435-1807 | — |
| DaVita Research Site | Henderson | Nevada | 89052-5548 | — |
| DaVita Research Site | Las Vegas | Nevada | 89128-0804 | — |
| DaVita Research Site #1 | El Paso | Texas | 79835-2200 | — |
| DaVita Research Site | El Paso | Texas | 79835-2200 | — |
| DaVita Research Site #1 | Houston | Texas | 77054-3836 | — |
| DaVita Research Site | Houston | Texas | 77054-3836 | — |
| DaVita Research Site #1 | San Antonio | Texas | 78258-4800 | — |
| DaVita Research Site #2 | San Antonio | Texas | 78258-4800 | — |
| DaVita Research Site | San Antonio | Texas | 78258-4800 | — |
| DaVita Research Site | The Woodlands | Texas | 77384-3024 | — |
| DaVita Research Site #1 | Norfolk | Virginia | 23502-3235 | — |
| DaVita Research Site | Norfolk | Virginia | 23502-3235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06901505, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 22, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06901505 live on ClinicalTrials.gov.